Dave Danielsen is the CEO of CairnSurgical, a clinical-stage medical device company in Lebanon, New Hampshire, that spun out of Dartmouth in 2015. He leads development of the Breast Cancer Locator System, a patient-specific, 3D-printed surgical guide paired with visualization software that helps surgeons see a tumor's size, shape, and location before a lumpectomy and remove it with cleaner margins. A West Point graduate with a Tuck School MBA, Danielsen has spent his career running commercial-stage health and diagnostics companies, and is now steering CairnSurgical through its U.S. pivotal trial, FDA submission, and early commercial launch in Europe.
Gregory Fischer is the co-founder and CEO of AiM Medical Robotics, a Worcester, Massachusetts company building a portable, MRI-compatible surgical robot for neurosurgery. A robotics engineer with a PhD from Johns Hopkins, Fischer spent nearly two decades as a professor at Worcester Polytechnic Institute, where he directed the Automation and Interventional Medicine (AIM) Robotics Lab and founded the PracticePoint medtech R&D center. He turned his NIH-funded research into a company aiming to bring real-time image guidance and submillimeter robotic precision into the operating room, with a first-in-human clinical study on the horizon after a $8.1 million Series A in 2025.